This track will explore the latest innovations in neuroimaging technologies, including MRI, CT, and PET scans. Emphasis will be placed on their applications in diagnosing and monitoring neurological disorders.

This session will focus on the underlying mechanisms of neurodegenerative diseases such as Alzheimer's and Parkinson's. Discussions will include novel therapeutic approaches and clinical trials aimed at disease modification.

This track will delve into the neurobiological mechanisms of pain and their implications for treatment. Researchers will present findings on both pharmacological and non-pharmacological pain management strategies.

This session will investigate the role of neuroinflammation in various neurological conditions, including multiple sclerosis and stroke. The focus will be on potential therapeutic targets to modulate inflammatory responses.

This track will present research on cognitive processes and their neural correlates, including memory, attention, and decision-making. The implications for understanding cognitive impairments in neurological disorders will also be discussed.

This session will address unique challenges in pediatric neurology, including developmental disorders and epilepsy. Innovative treatment approaches and their outcomes will be highlighted.

This track will focus on the genetic underpinnings of various neurological diseases, including hereditary neuropathies and syndromes. Advances in genetic testing and personalized medicine will be key discussion points.

This session will explore the intersection of psychology and neurology, focusing on assessment tools and therapeutic interventions for cognitive disorders. Case studies and evidence-based practices will be presented.

This track will cover the latest research in stroke prevention, acute management, and rehabilitation strategies. Emphasis will be placed on multidisciplinary approaches to improve patient outcomes.

This session will address the ethical challenges faced in neurology and neuroscience research, including informed consent and the use of neurotechnology. Discussions will aim to establish best practices for ethical compliance.

This track will explore the application of artificial intelligence and machine learning in neurology, including diagnostic tools and predictive analytics. The potential impact of these technologies on patient care will be critically examined.